KATHRYN ESQUIVEL: Open Payments
NPI 1245976497 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,312 in 44 payments from 13 companies in 2025. Trend: 2023 $1,614 · 2024 $1,921 · 2025 $2,312
Food & beverage: $2,232Education: $80
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $353 |
| Syndax Pharmaceuticals, Inc. | 8 | $346 |
| SOBI, INC | 6 | $341 |
| Astellas Pharma US Inc | 5 | $252 |
| AstraZeneca Pharmaceuticals LP | 4 | $224 |
| ABBVIE INC. | 3 | $191 |
| TAIHO ONCOLOGY, INC. | 2 | $152 |
| Adaptive Biotechnologies Corporation | 2 | $146 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 3 | $94 |
Products named: JAKAFI, Cresemba, Vonjo, CALQUENCE, clonoSEQ, REVUFORJ, OJJAARA, LONSURF.
Industry payments across TX — which companies pay providers there.
